Top compounds associated with response to IER5L


Feature Type Standardized
Nominal ANOVA
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.049 0.2
mRNA bendamustine CTRPv2 pan-cancer AAC -0.052 0.2
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA marinopyrrole A CTRPv2 pan-cancer AAC -0.06 0.2
mRNA VX-680 CTRPv2 pan-cancer AAC -0.15 0.2
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA Nilotinib CCLE pan-cancer AAC -0.072 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.2
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.045 0.2
Download CSV